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Genetic risk variants for brain disorders are
enriched in cortical H3K27ac domains
Eilis Hannon1, Sarah J. Marzi2, Leonard S. Schalkwyk3 and Jonathan Mill1*
Abstract
Most variants associated with complex phenotypes in genome-wide association studies (GWAS) do not directly
index coding changes affecting protein structure. Instead they are hypothesized to influence gene regulation, with
common variants associated with disease being enriched in regulatory domains including enhancers and regions of
open chromatin. There is interest, therefore, in using epigenomic annotation data to identify the specific regulatory
mechanisms involved and prioritize risk variants. We quantified lysine H3K27 acetylation (H3K27ac) - a robust
mark of active enhancers and promoters that is strongly correlated with gene expression and transcription factor
binding – across the genome in entorhinal cortex samples using chromatin immunoprecipitation followed by
highly parallel sequencing (ChIP-seq). H3K27ac peaks were called using high quality reads combined across all
samples and formed the basis of partitioned heritability analysis using LD score regression along with publicly-
available GWAS results for seven psychiatric and neurodegenerative traits. Heritability for all seven brain traits was
significantly enriched in these H3K27ac peaks (enrichment ranging from 1.09–2.13) compared to regions of the
genome containing other active regulatory and functional elements across multiple cell types and tissues. The
strongest enrichments were for amyotrophic lateral sclerosis (ALS) (enrichment = 2.19; 95% CI = 2.12–2.27), autism
(enrichment = 2.11; 95% CI = 2.05–2.16) and major depressive disorder (enrichment = 2.04; 95% CI = 1.92–2.16).
Much lower enrichments were observed for 14 non-brain disorders, although we identified enrichment in cortical
H3K27ac domains for body mass index (enrichment = 1.16; 95% CI = 1.13–1.19), ever smoked (enrichment = 2.07; 95%
CI = 2.04–2.10), HDL (enrichment = 1.53; 95% CI = 1.45–1.62) and trigylcerides (enrichment = 1.33; 95% CI = 1.24–1.42).
These results indicate that risk alleles for brain disorders are preferentially located in regions of regulatory/enhancer
function in the cortex, further supporting the hypothesis that genetic variants for these phenotypes influence gene
regulation in the brain.
Keywords: H3K27ac, Active enhancer, Promoter, GWAS, Brain disorder, LD score regression, Psychiatric illness,
Neurodegenerative disease, Epigenetics
Main text
There has been major progress in identifying genetic risk
variants for complex brain traits including neurodegen-
erative diseases (for example Alzheimer’s disease and
amyotrophic lateral sclerosis [1–3]) and neuropsychiatric
illnesses (for example schizophrenia and major depres-
sive disorder [4–7]). A key challenge is to understand
the biological effects of these genetic risk factors, espe-
cially because the actual gene(s) involved in mediating
phenotypic variation are not necessarily the closest to
the most significant genetic variant in genome-wide
association studies (GWAS). The majority of GWAS
variants do not directly index or tag coding changes
affecting protein structure. Instead, common variants
associated with disease are preferentially located in regu-
latory domains such as active enhancers and regions of
open chromatin [8, 9], and therefore are hypothesized to
act by influencing gene regulation [10]. There is, there-
fore, much interest in using epigenomic data to improve
our understanding of how genetic variants associated
with complex disease mediate differences in gene activity
and regulation. Given the tissue-specific nature of gene
regulation, it is critical these relationships are explored
in relevant tissues; existing epigenomic annotation data
* Correspondence: J.Mill@exeter.ac.uk
1University of Exeter Medical School, RILD Building, Royal Devon & Exeter
Hospital, University of Exeter, Barrack Rd, Exeter EX2 5DW, UK
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hannon et al. Molecular Brain            (2019) 12:7 
https://doi.org/10.1186/s13041-019-0429-4
has been largely generated in easily accessible tissues
and cells, or commercially available cell lines. In particu-
lar, datasets based on the human brain are lacking, limit-
ing the downstream interpretation of GWAS findings
for brain traits. Recently, we quantified genome-wide
patterns of lysine H3K27 acetylation (H3K27ac) - a
robust mark of active enhancers and promoters that is
strongly correlated with gene expression and transcrip-
tion factor binding – using ChIP-seq in an extensive
collection of entorhinal cortex samples (n = 47) [11]. In
this study, we used these data to perform enrichment
analyses of GWAS variants for a range of brain traits
(attention-deficit hyperactivity disorder (ADHD), Alzhei-
mer’s disease, autism, amyotrophic lateral sclerosis
(ALS), major depressive disorder, bipolar disorder and
schizophrenia) using linkage disequilibrium (LD) score
regression [12] to test the hypothesis that the majority of
these variants act by influencing gene regulation in
the brain.
Detailed methods on the experimental procedures and
informatics pipeline used to derive the set of cortical
H3K27ac peaks have been previously described [11].
Briefly, post-mortem entorhinal cortex samples from 47
donors were provided by the MRC London Neurodegen-
erative Disease Brain Bank (https://www.kcl.ac.uk/ioppn/
depts/bcn/index.aspx). The entorhinal cortex, which is
located in the medial temporal lobe, has an important
role in memory formation and has been implicated in a
range of neuropsychiatric and neurological phenotypes
[13]. We annotated genome-wide patterns of H3K27ac
in the entorhinal cortex using chromatin immunoprecip-
itation (ChIP) followed by highly parallel sequencing
(ChIP-seq). After stringent quality control of the raw
H3K27ac ChIP-seq data, we obtained a mean of
30,032,623 (SD = 10,638,091) sequencing reads per sam-
ple, representing the most extensive analysis of H3K27ac
in the human entorhinal cortex yet undertaken.
H3K27ac peaks were called from the combined set of
high quality mapped reads across all samples using
MACS2 [14], and filtered to exclude those located on
sex chromosomes, in unmapped contigs and mitochon-
drial DNA. In total, we generated a final dataset of
178,454 autosomal entorhinal cortex H3K27ac peaks
which were used in the analyses presented here.
To test for enrichment of GWAS variants in H3K27ac
peaks from adult cortex, we performed partitioned
heritability analysis using the LD score regression
software (https://github.com/bulik/ldsc) [12, 15]. Briefly,
this method assumes that the test statistic for a given
genetic variant also captures the effect of all other vari-
ants in LD with it; the number of additional variants
tagged by the particular variant under consideration is
measured by its ‘LD score’. Genuine polygenic effects
are present, therefore, if the test statistics positively
correlate with the LD scores. The method can be applied
either across the genome to derive an estimate of total
heritability or to subsets of genetic variants annotated to
genomic features, so called partitioned heritability.
Enrichment is determined if there is a stronger, positive
correlation between the test statistics and LD scores for
variants within a category relative to other categories.
LD scores were generated based on custom annotations
derived from our H3K27ac peaks and 1000 genomes
reference data (downloaded alongside the software from
https://data.broadinstitute.org/alkesgroup/LDSCORE/).
The baseline model proposed by Finucane et al. [15] -
based on the union of non-specific functional annotation
categories including coding, UTR, promoters, introns,
histone marks (H3K4me1, H3K4me3, H3K9ac5,
H3K27ac), DNase I hypersensitivity site (DHS) regions,
chromHMM/Segway predictions of underlying chroma-
tin states derived from ENCODE annotations, regions
that are conserved in mammals, super-enhancers and
active enhancers - was taken as the background for
enrichment testing. Genetic variants were annotated to
two non-overlapping categories defined as follows: 1)
entorhinal cortex H3K27ac peaks and 2) any other func-
tional annotation category included in the baseline
model. Heritability statistics for each annotation cat-
egory were then calculated using publicly available
GWAS results for seven psychiatric and neurodegenera-
tive traits (ADHD [16], Alzheimer’s disease [1], autism
[17], amyotrophic lateral sclerosis (ALS) [2], major
depressive disorder [7], bipolar disorder [5] and
schizophrenia [4, 6, 18]) and 14 non-brain phenotypes
(birth length [19], body mass index (BMI) [20, 21],
height [21, 22], cigarettes per day [23], ever smoked [23],
coronary artery disease [24], Crohn’s disease [25], in-
flammatory bowel disease [25], ulcerative colitis [25],
high density lipoprotein (HDL) [26], low density lipopro-
tein (LDL) [26], total cholesterol [26], triglycerides [26]
and type 2 diabetes [27]) (See Additional file 1: Table S1).
Enrichment statistics for each GWAS trait were calculated
as the proportion of heritability attributed to that category
divided by the proportion of SNPs annotated to that
category, with 95% confidence intervals used to identify
significant enrichment statistics. These represent the
enrichment relative to the set of more broadly defined
functional elements derived from cross-tissue datasets
included in the baseline model.
We first estimated the total heritability of each trait
using variants annotated to any functional genomic
annotation category to confirm that the included GWAS
had sufficient power to quantify heritability with enough
precision to permit downstream enrichment analyses.
Across the seven brain traits, the total heritability esti-
mates ranged from 0.0535 for ALS (95% confidence
interval (0.0321, 0.0749)) to 0.237 for schizophrenia
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(95% confidence interval (0.214, 0.260)) (Fig. 1a). Next,
we estimated the partitioned heritability attributable to
variants located within entorhinal cortex H3K27ac
peaks. This ranged from 0.0302 for Alzheimer’s disease
(95% confidence interval (0.013, 0.0478)) to 0.146 for
schizophrenia (95% confidence interval (0.121, 0.170));
all seven brain traits had significantly non-zero estimates
of heritability within H3K27ac peaks (Table 1). Finally,
we compared partitioned heritability estimates between
entorhinal cortex H3K27ac peaks and more broadly
defined functionally active regions of the genome identi-
fied across multiple cell types. For all seven brain traits,
heritability was enriched within the entorhinal cortex
H3K27ac peaks (Fig. 1b). The strongest enrichment was
for ALS (enrichment = 2.20; 95% confidence interval
(2.12, 2.27)), followed by autism (enrichment = 2.11; 95%
confidence interval (2.05, 2.16)) and major depressive
disorder (enrichment = 2.04; 95% confidence interval
(1.92, 2.16)); the lowest enrichment was for Alzheimer’s
disease (enrichment = 1.10; 95% confidence interval
(1.05, 1.15). Enrichments for all seven brain traits
remained significant when correcting for the number of
independent tests performed (Additional file 2: Table
S2). We next compared these results to those for the 14
non-brain phenotypes; although most were found to
have non-zero heritability estimates for variants located
within entorhinal cortex H3K27ac peaks, these were
generally not enriched relative to functional elements
defined across multiple tissue types. The exceptions were
for body mass index (BMI) (enrichment = 1.16; 95% con-
fidence interval (1.13, 1.19)), ever smoked (enrichment =
2.07; 95% confidence interval 2.04, 2.10), high density
lipoprotein (HDL) (enrichment = 1.53; 95% confidence
interval (1.45, 1.62)) and triglycerides (enrichment =
1.33; 95% confidence interval = (1.24, 1.42)). These re-
sults are interesting given that both BMI and smoking
are known to have a neurobiological component, and it
is plausible that genetic variation associated with these
traits may have mechanistic effects in the cortex.
In summary, we report an enrichment of heritability
within active regions of regulatory and enhancer
function in the adult entorhinal cortex for seven brain
disorders. This augments an existing body of evidence
that genetic variants identified in GWAS are involved in
gene regulation [10]. Furthermore, it uses regulatory do-
mains defined in the relevant tissue and demonstrates
that these regions are more informative than functional
elements defined across a panel of tissues and cell types,
highlighting the importance of generating cell-type and
tissue-specific epigenomic annotation datasets. Although
our data represents the largest entorhinal cortex
H3K27ac dataset generated to date, we were restricted
to performing a global enrichment analysis. Future
analyses in larger numbers of samples should aim to
undertake a genetic analysis of each peak and align these
results with GWAS results in order to identify the
A
B
Fig. 1 Enrichment of heritability within entorhinal cortex H3H27ac peaks. a Bar plot of total heritability estimates calculated across genetic
variants located within any functional element. b Bar plot of cortical H3K27ac enrichment statistics. Enrichment was calculated as the proportion
of heritability divided by the proportion of variants within autosomal H3K27ac peaks in the entorhinal cortex, relative to values for the set of
more broadly defined functional elements derived from cross-tissue datasets. Error bars represent 95% confidence intervals; dashed horizontal
lines indicate null values
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specific peaks, and ultimately genes, associated with gen-
etic variants identified in genetic studies of brain traits.
There are a number of limitations to our study. First,
although one of the strengths of our study is the use of
cortical H3K27ac data, our ChIP-seq analyses were
performed on bulk tissue and future studies should aim
to generate epigenomic annotation data for specific
neural cell-types [28]. Second, we have only considered
one specific epigenetic mark, H3K27ac; future studies
exploring a more comprehensive set of marks may yield
insights into the exact mechanism by which genetic
variants influence gene regulation. Third, the H3K27ac
data were generated in elderly adult post-mortem brain,
which may be less relevant for neurodevelopmental
brain phenotypes such as autism, ADHD and schizo-
phrenia. In conclusion, our results support the hypoth-
esis that genetic variants associated with brain disorders
exert their effect through gene regulation in the brain.
Future studies should aim to identify the specific regula-
tory elements affected by genetic variants associated
with brain disorders and the genes that are transcrip-
tionally altered by these differences.
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